₹80.00
ABIBEC-N
ABIBEC-N is the combination of various compositions such as Beclomethasone Dipropionate, Neomycin Sulphate and Clotrimazole Cream. This medication is extensively used to prevent bacterial skin infections. Betamethasone is a powerful corticosteroid that acts by decreasing swelling, redness, and itching caused by a skin infection. Neomycin Sulphate is an antibiotic that inhibits bacterial growth, whereas Clotrimazole is an antifungal that inhibits fungus growth. They successfully cure the infection and alleviate skin irritation when used together.
Precautions For Beclomethasone Dipropionate, Neomycin Sulphate And Clotrimazole Cream
Beclomethasone Dipropionate, Neomycin Sulphate and Clotrimazole Cream should be applied after washing the face and making it dry. Take a little amount of this cream and just apply by fingertips but do not expose to the sun after applying this. Do not forget to consult the doctor before using this cream.
Side Effects Of Beclomethasone Dipropionate, Neomycin Sulphate And Clotrimazole Cream
Beclomethasone Dipropionate, Neomycin Sulphate and Clotrimazole Cream rarely cause any kind of side effects. Commonly, this medicine may cause mild itching that is also for a temporary time period. If the patient faces any kind of side effect then let the doctor know.
Abigail Healthcare is an ISO certified derma company that has a well-known reputation in the market. Our company has left a remarkable remark in the market through the quality derma products. Abigail Healthcare is a third party Beclomethasone Dipropionate, Neomycin Sulphate and Clotrimazole Cream Manufacturer and supplier in India. Moreover, our company is backed by well qualified and experienced staff that works tirelessly at premises. We also provide PCD derma franchise in Beclomethasone Dipropionate, Neomycin Sulphate and Clotrimazole Cream on a monopoly basis.
Pack Size | |
---|---|
Brand Name | ABIBEC-N |
Composition | Beclomethasone Dipropionate 0.025%w/w + Neomycin Sulphate 0.5%w/w + Clotrimazole 1% w/Wcream |
There are no enquiries yet.